The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study
Public ClinicalTrials.gov record NCT01211522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
MIND-USA Study: Modifying the Impact of ICU-Associated Neurological Dysfunction
Study identification
- NCT ID
- NCT01211522
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Enrollment
- 566 participants
Conditions and interventions
Interventions
- Haloperidol Drug
- Placebo Drug
- Ziprasidone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 13, 2011
- Primary completion
- Aug 27, 2017
- Completion
- Jul 18, 2018
- Last update posted
- Nov 17, 2019
2011 – 2018
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Denver Health/University of Colorado Health Sciences Center | Denver | Colorado | 80204-4507 | — |
| Yale University Medical Center | New Haven | Connecticut | 06520-8057 | — |
| Indiana University | Indianapolis | Indiana | 46202-2915 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114-2696 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109-5360 | — |
| Albert Einstein Medical College-Montefiore Medical Center | The Bronx | New York | 10461 | — |
| University of North Carolina - Chapel Hill | Chapel Hill | North Carolina | 27599-7248 | — |
| Moses Cone Health System | Greensboro | North Carolina | 27410 | — |
| The Ohio State Medical Center | Columbus | Ohio | 43210-1228 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104-6205 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232-8300 | — |
| Baylor Health Care System | Dallas | Texas | 75206 | — |
| University of Washington | Seattle | Washington | 98195-9472 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01211522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2019 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01211522 live on ClinicalTrials.gov.